返回
Stem cell-based therapy for COVID-19
DOI:10.1016/j.intimp.2023.110890.png)
摘要
En 中文
While The World Health Organization (WHO) has announced that COVID-19 is no longer a public health emergency of international concern(PHEIC), the risk of reinfection and new emerging variants still makes it crucial to study and work towards the prevention of COVID-19. Stem cell and stem cell-like derivatives have shown some promising results in clinical trials and preclinical studies as an alternative treatment option for the pulmonary illnesses caused by the COVID-19 and can be used as a potential vaccine. In this review, we will systematically summarize the pathophysiological process and potential mechanisms underlying stem cell-based therapy in COVID-19, and the registered COVID-19 clinical trials, and engineered extracellular vesicle as a potential vaccine for preventing COVID-19.
Keyword:
COVID-19
Mesenchymal stem cells
Extracellular vesicle
Cell -based therapy
Clinical trials
Vaccines
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
4.7
论文数:
1.6W
被引数:
4.1W
机构
引用论文
Performance analysis of energy-harvesting relay selection systems with multiple antennas in presence of transmit hardware impairments发射硬件损伤情况下多天线能量采集中继选择系统的性能分析
Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries
LANCET
IF88.5
Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?
THORAX
IF7.7

